Introduction
Obesity is a major health problem worldwide and is a wellknown risk factor for coronary heart disease, type 2 diabetes and hypertension. 1, 2 Genetic background, daily physical activity and diet composition have been identified as factors that contribute to the development of obesity. In particular, the quantity of dietary fat ingested is an important contributor to excessive weight gain. 3, 4 Fat balance, calculated as the difference between digestible fat intake and fat oxidation, has been implicated as a key regulator of body fat (BF). 5 Furthermore, the type of dietary fat influences fat utilization. [6] [7] [8] Diacylglycerol (DAG) is a natural component of various edible oils. 9 DAG oil (containing 480% DAG) has a similar taste, appearance and fatty acid composition with conventional triacylglycerol (TAG) oil. 10 Recent studies have reported that DAG oil has nutritional properties that are distinct from those of TAG oil because of differences in chemical structure. 11 Human studies in the US and Japan have demonstrated that long-term consumption of a diet containing DAG oil enhances loss of body weight and BF compared with a TAG oil with a similar fatty acid composition. 12, 13 Animal studies have shown that both b-oxidation and expression of lipid metabolism-related genes in the liver and small intestine are enhanced with chronic DAG oil ingestion compared with TAG oil ingestion. [14] [15] [16] Several human studies have shown greater fat oxidation and/or lower respiratory quotient with short-term DAG oil consumption (single meal, 17 1 8 and 4 days 18 ) compared with TAG oil consumption. Although, these studies examined the shorter-term effects of DAG oil, the longer-term effects of DAG oil consumption remain to be investigated. The purpose of this study was to determine whether repeated DAG oil consumption affects energy metabolism in overweight patients in a 14-day controlled feeding study. Simultaneously, we explored the effect of DAG oil consumption on dietary fat oxidation, as determined by the recovery rate of 13 C-stable isotope in the breath.
Patients and methods

Patients
Fourteen Japanese patients (eight men and six women; mean age±s.d., 40±5 years; mean BMI±s.d., 27.7±2.2 kg/m 2 )
were recruited from the Tokyo metropolitan area. All patients were apparently healthy based on their medical histories and were weight stable for at least 1 month before enrollment in the study. One female patient was postmenopausal. For the five premenopausal patients, energy metabolism was measured during the same phase of the menstrual cycle. The study protocol was approved by the clinical ethical committee of Clínica Emilio Moriguchi (Tokyo, Japan). All patients gave written informed consent to participate, after having received verbal and written explanation of the study. The study was performed in accordance with the principles of the Helsinki Declaration.
Test oils
The DAG oil used in this study was prepared from soybean and rapeseed oils using immobilized lipase. 19 The prepared DAG oil contained more than 80 wt.% DAG, and the ratio of 1(3),2-diacylglycerol to 1,3-diacylglycerol was approximately 3:7. TAG oil was prepared by mixing rapeseed, safflower and perilla oils, such that the fatty acid composition was similar to that of the DAG oil. Fatty acid and glyceride compositions of the test oils are shown in Table 1 . The oils were incorporated into a mayonnaise-like food that contained 66.3 wt.% of the respective test oil. The taste, appearance and physical properties of mayonnaise-like foods used as the test article were similar between DAG oil and TAG oil, so that patients and the study personnel were not able to distinguish between them.
Experimental design
This trial was a randomized, double-blind, crossover, controlled study, which consisted of two 14-day dietary treatment phases, separated by a 2-week washout period. Baseline energy metabolism was measured over 23 h using a whole-room respiratory chamber at Kao Health Care Food Research Center, Tokyo, Japan. Subsequently, patients were randomly assigned to either the TAG oil or DAG oil diet during the first treatment phase. After the washout period, patients consumed the alternate test diet during the second treatment phase. Energy metabolism was measured over 23 h at the end of each 14-day diet treatment phase (end point).
During each dietary treatment phase, patients were required to consume all prepackaged meals provided by the study coordinator. Patients were also instructed not to consume any energy-containing foods or drinks other than those supplied by the study coordinator. In addition, patients were instructed to maintain their habitual physical activity patterns. During the washout period, patients resumed their habitual lifestyle, including usual dietary intake.
Anthropometric and body composition measurements Body weight was measured using a digital balance accurate to 0.01 kg (CQ100LW, Ohaus Corp., NJ, USA) at baseline and the end of each treatment phase before measurement of energy expenditure (EE) in the respiratory chamber. Body composition was measured using whole-body dual-energy X-ray absorptiometry (DEXA, Hologic Inc., QRD 4500 W, Waltham, MA, USA) at baseline and the end of each treatment phase. Absolute fat mass (FM), and fat-free mass (FFM) were determined using Hologic Systems Software, according to the procedures outlined in the Hologic QRD 4500 User's Guide. BF ratio was calculated using the following equation:
Analytic procedures Blood samples were collected from patients after an overnight fast at baseline and the end of each dietary treatment, before entering the respiratory chamber. All analyses, except for glucose, were performed in serum. The concentrations of Greater fat oxidation with diacylglycerol oil M Hibi et al triglyceride, non-esterified fatty acid (NEFA) and plasma glucose were measured using standard enzymatic techniques. The concentrations of insulin and adiponectin were assayed using an immunoenzymatic method. Leptin concentrations were determined using a radioimmunoassay method. All analysis was performed by SRL Inc. (Tokyo, Japan). Urine samples were collected while patients were in the respiratory chamber; the samples were analyzed for total nitrogen to calculate protein oxidation. Urine samples were weighed and urinary total nitrogen was measured in triplicate using a chemiluminescent nitrogen analyzer (TN-100, Mitsubishi Chemical Corp., Kanagawa, Japan).
Dietary treatment
Seven-day menu cycles consisting of typical Japanese foods were utilized for the test diets during each treatment phase. All meals were individually prepared and weighted by a dietitian. The energy intake (EI) of each patient was calculated by multiplying estimated basal metabolic rate by a physical activity level of 1.4. Basal metabolic rate was calculated from body weight, height and age using the Harris-Benedict equation. 20 The macronutrient composition of the test diet was as follows: 55% of the calories from carbohydrate, 15% from protein and 30% from fat. Patients were acclimatized to the test oil treatment before chamber measurement by consuming 10 g of the test oil in the evening meal. The DAG oil diets and TAG oil diets were identical except for the difference in test oil. Patients consumed test meals containing TAG oil for 3 days before the baseline measurement of energy metabolism in the respiratory chamber.
Chamber protocol
The patients remained in the respiratory chamber from 0800 hours on day 0 until 0700 hours on day 1 of first phase, and from 0800 hours on day 14 until 0700 hours on day 15 of each treatment phase. Breakfast, lunch and dinner were provided in the respiratory chamber at 0900 hours, 1400 and 2100 hours, respectively. Patients were allowed ad libitum access to water. All food consumed by patients in the respiratory chamber was prepared in the metabolic kitchen located near the respiratory chamber by a dietitian. During assessment of energy metabolism, the patients' EI was reduced to basal metabolic rate multiplied by a physical activity factor of 1.3, due to limited physical activity in the respiratory chamber. The macronutrient composition of the test diet was as follows: 55% of the calories from carbohydrate, 15% from protein and 30% from fat. Fifty percent of total fat was provided by the test oil. Mean intakes of the TAG and DAG oil diets while patients were confined to the respiratory chamber were identical (36.1 ± 6.6 g day
À1
). The total energy provided by the test diet was allocated as follows: 30% of energy was consumed at breakfast, 30% at lunch and 40% at dinner. The patients were instructed to be in bed at 0000 hours and were awakened at 0630 hours. The patients performed 20 min of cycle ergometry (Aerobike 75XL-II, Combi Wellness Co. Ltd, Tokyo, Japan) at an intensity that elicited a heart rate of 120 beats min À1 at 1300 and 2000 hours.
The respiratory chamber was previously described. 18 Briefly, the 16-m 3 whole-room respiratory chamber temperature was set at 25 1C, the humidity was controlled at 50% and the fresh airflow rate was 100 l min
. Sample air was analyzed using a mass spectrometer (Thermo Fisher Scientific, VG PRIMA dB, Cheshire, UK), which was calibrated biweekly using standard gas (N 2 ; 78.08%, CO 2 ; 0.033%, O 2 ; 20.95% and Ar; 0.934%). Oxygen consumption (VO 2 ) and carbon dioxide production (VCO 2 ) were calculated using the method reported by Brown et al. 21 The 23-h VO 2 and VCO 2 measured during the patients' stay in the respiratory chamber were extrapolated to 24-h VO 2 and VCO 2 using the data collected during the hour before the patient left the chamber. Twenty-four hour total EE (TEE) was calculated from 24-h VO 2 and VCO 2 . 22 Respiratory quotient (RQ) fat oxidation, carbohydrate (CHO) oxidation and protein oxidation were calculated using previously reported equations. 23 Physical activity in the respiratory chamber was measured using a Doppler radar system. Sleeping metabolic rate (SMR) was defined as the lowest mean EE over three consecutive hours between 0000 and 0630 hours. 24 Activityinduced thermogenesis (AIT) and dietary-induced thermogenesis (DIT) were calculated by plotting EE against radar output averaged over 30-min periods. 25 The intercept of the regression line at the lowest radar output corresponds to EE during inactivity, that is, resting metabolic rate (RMR), which is comprised of SMR and DIT. 26 Energy balance was determined by subtracting TEE from EI.
Dietary fat oxidation assessment 13 C-labeled triolein probes were synthesized from [1- 13 C] oleic acid (purity of oleic acid 499%, 13 C499%, Isotec Inc., OH, USA) and free glycerol using the method described by Watanabe et al., 19 and were purified using silica gel liquid chromatography. The glyceride composition of each probe was determined by gas-liquid chromatography. 13 C-labeled triolein at a dose of 900 mg was added to both the DAG oiland TAG oil-containing breakfasts consumed at 0900 hours. Breath samples were collected in aluminum bags (GL Science Inc., Tokyo, Japan) before breakfast, hourly for a period of 10 h, and again after 15 and 22 h. Enrichment of 13 CO 2 in the patient's breath was analyzed by isotope ratio mass spectrometry (Sercon, ANCA-GSL, Cheshire, UK). Rates of 13 
Statistical analysis
Data are presented as means ± s.d. Differences in TEE, RMR, SMR, DIT, AIT, RQ, CHO oxidation, protein oxidation and fat oxidation between the TAG and DAG oil dietary treatments were analyzed using paired t-tests. The relationships between the metabolic parameters and body composition were assessed using Pearson's correlation coefficient. Analysis of variance (ANOVA) models were generated using the PROC MIXED procedure. Repeated-measures ANOVA was used to assess treatment-by-time interactions for 13 C dose recovered in breath. All statistical analyses were performed using the SAS Systems for Windows (release 8.2, SAS Institute Inc, Cary, NC, USA).
Results
Twenty volunteers were enrolled in this study. However, one patient did not complete the study due to conditions unrelated to this study. Five patients were excluded from the analysis due to the following reasons: one patient scored low adherence (o90%) to the test diet, as determined from the diet record; two patients experienced flu with high fever; and, two patients experienced diarrhea. Among the patients included in the analysis, the diet records showed high compliance with the test diet during the treatment phase (approximately 97%). The baseline physical characteristics and serum lipids of the participants are shown in Table 2 . EE and substrate oxidation at baseline are shown in Table 3 . Both 24-h TEE and SMR positively correlated with FFM at baseline (FFM vs TEE: r ¼ 0.967, Po0.001; FFM vs SMR: r ¼ 0.937, Po0.001).
Body weights at the end of each treatment phase were 75.3±13.4 kg after TAG oil consumption and 75.6±13.7 kg with DAG oil consumption; there were no significant differences in either body weight or body composition between treatments (Table 4) . Body weight decreased significantly from baseline after consumption of both a TAG oil diet (À1.9 ± 1.0 kg, Po0.001) and a DAG oil diet (À1.5±0.5 kg, Po0.001).
TEE and its components at the end of each treatment phase are shown in Table 5 . TEE was similar with TAG oil and DAG oil consumption. RMR was greater (Po0.05) with DAG oil consumption (1766±337 kcal day À1 ) than with TAG oil consumption (1680 ± 316 kcal day
À1
). SMR, DIT and AIT were not significantly different between treatments. Energy balance measured in the respiratory chamber was slightly positive for both treatments and did not differ between TAG and DAG oil consumption (252 ± 81 and 225 ± 85 kcal, respectively). Fat oxidation was significantly greater (Po0.05) with DAG oil consumption (78.6±19.6 g day À1 ) than with TAG oil consumption (72.6 ± 14.9 g day À1 ), in Table 6 . CHO oxidation and protein oxidation did not differ significantly between treatments. RQ averaged over 24 h tended to be lower (P ¼ 0.066) with DAG oil consumption than with TAG oil consumption.
Dietary fat oxidation was assessed for 22 h by the measurement of 13 CO 2 after ingestion of 13 C-labeled triolein provided in the test breakfast on day 14. The assessment was conducted in a respiratory chamber at the end of each treatment phase. The recovery rates of 13 CO 2 in the breath peaked after 5 h and nearly returned to baseline levels after 22 h. Cumulative recovery of 13 CO 2 in the breath of all Figure 1 . The repeated-measures ANOVA showed a significant (Po0.01) treatment-by-time interaction over the time course of cumulative recovery of 13 CO 2 . The concentrations of triglyceride, NEFA, glucose, insulin, leptin and adiponectin at the end of treatment measured after an overnight fast are shown in Table 7 . There were no significant differences in non-esterified fatty acid, glucose, insulin, leptin and adiponectin between treatments.
Triglyceride was significantly lower (Po0.05) with DAG oil consumption compared with TAG oil consumption.
Discussion
The objective of this clinical feeding study was to compare the effects of 14 days of DAG oil consumption with TAG oil with a similar fatty acid composition on energy metabolism in overweight men and women. The results of this 14-day study, during which EI and macronutrient composition were tightly controlled, show that DAG oil consumption results in greater fat oxidation, dietary fat oxidation and RMR, which is comprised of SMR and DIT, compared with TAG oil consumption. However, there were no significant differences in TEE between DAG oil and TAG oil consumption, nor were there significant treatment differences in body weight or body composition.
In an animal study, Murase et al. 15 reported that mice fed with a DAG oil-containing diet for 8 months accumulated Abbreviations: AIT, activity-induced thermogenesis; DAG, diacylglycerol; DIT, diet-induced thermogenesis; RMR, resting metabolic rate; SMR, sleeping metabolic rate; TAG, triacylglycerol; TEE, total energy expenditure.
b Differences between treatments were evaluated using paired t-tests. Significantly greater than TAG oil consumption at the end of the treatment phase: Po0.05. b Differences between treatments were tested using paired t-tests. Significantly greater than TAG oil consumption at the end of treatment phase: Po0.05. b Differences between treatments were evaluated using paired t-tests. Significantly lower than the TAG oil diet at the end of the treatment phase: Po0.05.
Greater fat oxidation with diacylglycerol oil M Hibi et al significantly less BF compared with mice fed with a TAG oilcontaining diet with a similar fatty acid composition. Within the first 10 days, dietary DAG oil stimulated b-oxidation and lipid metabolism-related gene expression in the small intestine. In addition, Murata et al.
14 reported that hepatic b-oxidation-related enzyme activity increased in rats fed with DAG oil diet for 14 days compared with TAG oil diet. These reports suggest that DAG oil consumption enhances fat oxidation in animals, which is consistent with the results of this study. The present findings strengthen and extend previous observations from short-term human studies using a respiratory chamber, 8, 18 in which greater fat oxidation was observed with consumption of DAG oil compared with TAG oil. With regard to the magnitude of the increase in fat oxidation in short-term DAG oil consumption, Kamphuis et al. 8 observed significantly greater fat oxidation with consumption of a DAG oil-containing diet compared with a TAG oil diet (4.9 g day À1 on day 1 and 4.0 g day À1 on day 2).
In our previous study, 18 patients with a higher BF ratio showed greater fat oxidation by 4 g day À1 (NS) with DAG oil consumption. In contrast, this study showed that fat oxidation was increased by 6.0 g day À1 after 14 days of DAG oil consumption. The test oil dosages consumed by patients during measurement of EE in the respiratory chamber used in this study were similar to those used in previous studies. Several factors limit direct comparison between previous studies and this study, including differences in study protocol and patient background. Nevertheless, this study showed slightly greater fat oxidation than that observed in previous studies. This result may be explained by the dietary treatment with DAG oil before the measurement of EE in the respiratory chamber. Future studies are necessary to evaluate the contribution of the pre-chamber DAG oil treatment on the increase in fat oxidation. We observed that RMR, which is comprised of SMR and DIT, was 86 kcal day À1 greater with DAG oil consumption than with TAG oil consumption. However, TEE did not differ between treatments. Kamphuis et al. 8 reported that TEE, SMR and DIT during DAG oil dietary treatment were not significantly different than values measured during treatment with a TAG oil diet. Moreover, in our previous study, 18 TEE did not differ between DAG oil and TAG oil after a 4-day dietary treatment. It is possible that longer-term DAG oil consumption increases EE, whereas shorter-term consumption does not. The greater RMR associated with DAG oil consumption primarily resulted from an increase in DIT, rather than an increase in SMR. The reason for greater DIT with DAG oil consumption appears to be the distinct metabolism of DAG oil and TAG oil. Saito et al. 17 reported enhanced postprandial EE after DAG oil consumption compared with TAG oil consumption in humans. Similarly, medium-chain triacylglycerol (MCT) enhances fat metabolism due to its distinct metabolic pathway. 27 Previous studies in humans show increased postprandial EE and fat oxidation after both acute 7 and repeated 28, 29 MCT feeding, supporting the reduced weight gain observed with chronic 30 MCT consumption. St Onge et al. reported that MCT increased fat oxidation and EE in a 4-week crossover feeding studies including both women 28 and men. 29 MCT intake increased daily EE, extrapolated from 6.5 h of indirect calorimetry data, which equated to 50 kcal day À1 in women and 43 kcal day À1 in men by the end point of the study.
Consistent with the results of MCT feeding studies, the increase in EE after 14 days of DAG oil consumption observed in this study may have contributed to the greater reductions in body weight and fat with DAG oil consumption observed in previous weight-loss studies. 12, 13 In this study, the cumulative recovery rate of 13 CO 2 was assessed as an indicator of dietary fat oxidation. The 13 Clabelled triolein was used to determine if DAG consumption alters the oxidation of TAG derived from the test meal. Although there were no treatment differences in cumulative recovery rate of 13 CO 2 for 22 h, repeated-measures ANOVA indicated a significant treatment-by-time interaction for the time course of cumulative recovery of 13 CO 2 . Enhanced dietary fat oxidation with DAG oil consumption appeared to be associated with an increase in total (whole body) fat oxidation. This result may be explained by increased b-oxidation and lipid metabolism-related gene expression, as has been observed in animals fed with DAG oil-containing diets.
14-16 Sonko et al. 31 reported that, over a 24-h period, approximately 30% of dietary fat is oxidized and 470% of dietary fat is stored, based on whole-room indirect calorimetry and isotope-ratio mass spectrometry. The authors suggested that, over the long-term, this rate of fat storage might promote the development of obesity. The results of this study suggest that enhanced dietary fat oxidation, resulting from DAG oil consumption, may contribute to the prevention of obesity. However, additional studies with larger sample sizes are required to determine if the alteration in dietary fat oxidation is due to a change in total fat oxidation. Body weight was significantly reduced after consumption of either test diet for 14 days. In this study, the patients consumed an EI that was equal to basal metabolic rate multiplied by 1.4. This EI may have been hypocaloric, but there were no significant differences in body weight on day 14 between the two treatments. In previous studies, a decrease in body weight and BF were observed after 16-24 weeks of DAG oil consumption, suggesting that the 14-day period may not have been long enough to observe a reduction in body weight as a result of DAG oil consumption. 12, 13 In previous reports, body composition was shown to have a significant effect on energy metabolism. 32, 33 In this study, we compared EE and substrate oxidation without the confounding effect of treatment differences in body weight and body composition. Moreover, in this study, fasting triglyceride concentrations were lower after DAG oil consumption compared with TAG oil consumption. This change presumably resulted from altered lipid metabolism after 14 days of DAG oil consumption.
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In conclusion, consumption of DAG oil for 14 days results in greater oxidation of total and dietary fat, as well as simultaneous elevation in RMR compared with TAG oil consumption. Thus, enhanced energy metabolism may explain the greater loss of body weight and BF in overweight and obese individuals who consume DAG oil diet during weight loss.
